Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2020 Earnings

6MayConfirmed

Q3 2019

Q4 2019

Q1 2020

Q2 2020

-11

-9.88

-8.76

-7.64

Details

Expected EPS

-10.8003105

Actual EPS

-10.4574435

Surprise EPS

0.34

Surprise Percent

+3.17%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -10.4574435 per share for Q2 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.